The Effects of High Mobility Group Box-1 Protein in Human Vascular Smooth Muscle Progenitor Cells in Regard to the Occurrence of Allograft Vasculopathy after Heart Transplantation

Medicine & Life Sciences

1. High Mobility Group Proteins 100%
2. Vascular Smooth Muscle 97%
3. Smooth Muscle Myocytes 87%
4. Heart Transplantation 62%
5. Allografts 60%
6. Stem Cells 58%
7. Heart 25%
8. Transplants 18%
9. HMGB1 Protein 13%
10. Adventitia 12%
11. Graft Rejection 10%
12. Tunica Intima 10%
13. Lymphoid Tissue 10%
14. Cyclosporine 9%
15. Thoracic Surgery 8%
16. Endothelium 8%
17. Hyperplasia 8%
18. Coronary Vessels 8%
19. Skeletal Muscle 7%
20. Immune System 7%
21. Tissue Donors 7%
22. Spleen 7%
23. Transplantation 7%
24. Survival Rate 7%
25. Endothelial Cells 7%
26. Bone Marrow 7%
27. Medicine 7%
28. Neoplasms 6%
29. Cytokines 6%
30. Neoplasm Metastasis 6%
31. Kidney 5%
32. Lung 5%
33. Liver 5%